HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Patrick J Ward Selected Research

Triple Negative Breast Neoplasms

10/2016Panitumumab, Gemcitabine, and Carboplatin as Treatment for Women With Metastatic Triple-Negative Breast Cancer: A Sarah Cannon Research Institute Phase II Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Patrick J Ward Research Topics

Disease

8Neoplasms (Cancer)
10/2023 - 02/2004
5Breast Neoplasms (Breast Cancer)
06/2022 - 10/2018
2Prostatic Neoplasms (Prostate Cancer)
10/2023 - 02/2004
2Rectal Neoplasms (Rectal Cancer)
11/2015 - 06/2014
2Diarrhea
11/2015 - 06/2014
1Amenorrhea
02/2022
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2019
1Vascular Remodeling
01/2019
1Neoplasm Metastasis (Metastasis)
10/2018
1Triple Negative Breast Neoplasms
10/2016
1Arthritis (Polyarthritis)
10/2015

Drug/Important Bio-Agent (IBA)

3taxaneIBA
10/2023 - 10/2018
3Fluorouracil (Carac)FDA LinkGeneric
02/2022 - 06/2014
3Carboplatin (JM8)FDA LinkGeneric
12/2021 - 10/2016
3ErbB Receptors (EGF Receptor)IBA
12/2021 - 10/2016
2AnthracyclinesIBA
06/2022 - 01/2019
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2022 - 01/2019
2Docetaxel (Taxotere)FDA Link
12/2021 - 01/2019
2Taxoids (Taxanes)IBA
01/2019 - 10/2018
2Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2015 - 06/2014
2Capecitabine (Xeloda)FDA Link
11/2015 - 06/2014
1AntigensIBA
10/2023
1Hormones (Hormone)IBA
06/2022
1Doxorubicin (Adriamycin)FDA LinkGeneric
02/2022
1Epirubicin (Ellence)FDA LinkGeneric
02/2022
1atezolizumabIBA
12/2021
1Trastuzumab (Herceptin)FDA Link
12/2021
1Ado-Trastuzumab EmtansineIBA
12/2021
1B7-H1 AntigenIBA
12/2021
1pertuzumabIBA
12/2021
1Biomarkers (Surrogate Marker)IBA
12/2021
1Heat-Shock Proteins (Heat-Shock Protein)IBA
12/2019
1apatorsenIBA
12/2019
1Messenger RNA (mRNA)IBA
12/2019
1Pemetrexed (MTA)FDA Link
12/2019
1Antisense OligonucleotidesIBA
12/2019
1HSP27 Heat-Shock ProteinsIBA
12/2019
1VimentinIBA
01/2019
1Cadherins (E-Cadherin)IBA
01/2019
1eribulinFDA Link
01/2019
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2018
1Lapatinib (GW572016)FDA Link
10/2018
1cabazitaxelFDA Link
10/2018
1GemcitabineFDA Link
10/2016
1Panitumumab (Vectibix)FDA Link
10/2016
1Celecoxib (Celebrex)FDA Link
02/2004
13-Phosphoinositide-Dependent Protein KinasesIBA
02/2004

Therapy/Procedure

5Drug Therapy (Chemotherapy)
06/2022 - 06/2014
4Therapeutics
10/2023 - 10/2018
2Immunotherapy
10/2023 - 12/2021
2Neoadjuvant Therapy
01/2019 - 11/2015
1Castration
10/2023
1Segmental Mastectomy (Lumpectomy)
06/2022
1Simple Mastectomy
06/2022
1Operative Surgical Procedures
10/2015
1Radiotherapy
06/2014